Showing 1 - 3 of 3 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Ibudilast (KETAS®) is a non-selective cyclic nucleotide phosphodiesterase (PDE) inhibitor. It is an antithrombotic, antiasthmatic drug that is used for improving prognosis and relieving symptoms in patients suffering from ischemic stroke and for the ...
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Repirinast is an antiallergic drug developed and introduced into the market in Japan in 1987. It is a histamine release inhibitor. It has demonstrated effectiveness for treating bronchial asthma in humans.
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment ...